E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/30/2010 in the Prospect News High Yield Daily and Prospect News Liability Management Daily.

Elan accepts all $156 million of tendered 8 7/8%, floating-rate notes

By Marisa Wong

Madison, Wis., Sept. 30 - Elan Corp., plc said that its wholly owned subsidiaries, Elan Finance plc and Elan Finance Corp., received tenders for $15.5 million of 8 7/8% senior fixed-rate notes due 2013 and $139.5 million of floating-rate notes due 2013.

The companies launched an asset sale offer to purchase up to $186 million of the 8 7/8% senior notes and the floating-rate notes on Aug. 30. The offer expired at 11:59 p.m. ET on Sept. 29.

The amount of tendered 8 7/8% senior notes represents 3.3% of the total outstanding 8 7/8% notes, and the amount of tendered floating-rate notes represents 93% of the total outstanding floating-rate notes.

The companies said they will accept all tendered notes for purchase.

Holders will receive par plus accrued interest up to, but not including, the payment date, which is expected to be Sept. 30.

Following completion of the offer, approximately $449.5 million of the fixed-rate notes and approximately $10.5 million of the floating-rate notes will remain outstanding.

D.F. King & Co., Inc. was the information agent and depositary for the asset sale offer.

Based in Dublin, Ireland, Elan is a neuroscience-based biotechnology company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.